Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Teva
Cantor Fitzgerald
Dow
Fish and Richardson
Deloitte
Chubb
Queensland Health

Generated: June 18, 2018

DrugPatentWatch Database Preview

NESACAINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Nesacaine, and what generic alternatives are available?

Nesacaine is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in NESACAINE is chloroprocaine hydrochloride. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chloroprocaine hydrochloride profile page.
Drug patent expirations by year for NESACAINE
Pharmacology for NESACAINE
Ingredient-typeEsters
Drug ClassEster Local Anesthetic
Physiological EffectLocal Anesthesia
Synonyms for NESACAINE
133-16-4
2-(Diethylamino)ethyl 4-amino-2-chlorobenzoate
2-(Diethylaminoethyl)-4-amino-2-chlorobenzoate
2-Chloroprocaine
2-Diethylaminoethyl 4-amino-2-chloro-benzoate
2-diethylaminoethyl 4-amino-2-chlorobenzoate
3858-89-7 (hydrochloride)
4-14-00-01273 (Beilstein Handbook Reference)
4-amino-2-chlorobenzoic acid 2-(diethylamino)ethyl ester
5YVB0POT2H
8010AH
ABA-8840096
AC1L1RCM
AK389892
AKOS010575135
Benzoic acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl ester
BENZOIC ACID,4-AMINO-2-CHLORO-, 2-(DIETHYLAMINO)ETHYL ESTER
BRN 2808071
C-33053
C07877
C13H19ClN2O2
CC-10413
CHEBI:3636
CHEMBL1179047
Chlor-procaine
Chloroprocain
CHLOROPROCAINE
Chloroprocaine (INN)
Chloroprocaine [INN]
Chloroprocaine Hcl
Chloroprocaine hydrochloride
Chloroprocainum
Chloroprocainum [INN-Latin]
Chlorprocaine
Chlorprocainum
Cloroprocaina
Cloroprocaina [INN-Spanish]
CTK6E8444
D07678
D07NAJ
DB01161
DTXSID8022799
FT-0713386
GTPL7145
Halestyn
HSDB 3301
LS-35706
Nesacaine (TN)
Nesacaine MPF
Nesacaine-Ce
Nesacaine-MPF (TN)
OR062388
OR214096
Piocaine
SCHEMBL6676
SR-01000944416
SR-01000944416-1
UNII-5YVB0POT2H
VDANGULDQQJODZ-UHFFFAOYSA-N
ZINC1530938

US Patents and Regulatory Information for NESACAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa NESACAINE chloroprocaine hydrochloride INJECTABLE;INJECTION 009435-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa NESACAINE-MPF chloroprocaine hydrochloride INJECTABLE;INJECTION 009435-006 May 2, 1996 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa NESACAINE chloroprocaine hydrochloride INJECTABLE;INJECTION 009435-002 Approved Prior to Jan 1, 1982 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa NESACAINE-MPF chloroprocaine hydrochloride INJECTABLE;INJECTION 009435-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Medtronic
Julphar
AstraZeneca
Healthtrust
Citi
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.